HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced stability of urokinase-type plasminogen activator mRNA in metastatic breast cancer MDA-MB-231 cells and LLC-PK1 cells down-regulated for protein kinase C--correlation with cytoplasmic heterogeneous nuclear ribonucleoprotein C.

Abstract
In LLC-PK1 cells, urokinase-type plasminogen activator (uPA) mRNA has a short half-life of 70 min. We have previously demonstrated that most of the regulatory regions responsible for the rapid turnover of uPA mRNA in LLC-PK1 cells reside in its 3' untranslated region (3' UTR), where there are at least three regulatory sites, one of which is A+U-rich. This A+U-rich sequence mediates uPA mRNA stabilization induced by protein kinase C (PKC) down-regulation. In this work, we found that uPA mRNA is rather stable in MDA-MB-231 cells with a half-life of 17 h. We compared the stability of hybrid globin mRNA containing different parts of uPA mRNA in its 3' UTR and found that the A+U-rich sequence of uPA mRNA renders otherwise stable globin mRNA unstable in LLC-PK1 cells but not in MDA-MB-231 cells. We identified a cytoplasmic protein of 40 kDa (p40) which specifically interacts with the A+U-rich sequence. Levels of p40 activity as detected by ultraviolet cross-linking were higher in MDA-MB-231 and PKC-down-regulated LLC-PK1 cells than in untreated LLC-PK1 cells. Prior treatment of the cytoplasm with a specific antibody against heterogeneous nuclear ribonucleoprotein C (hnRNP C) significantly reduced p40 activity. These results suggest a correlation between the A+U-rich sequence-dependent uPA mRNA stabilization in vivo and the binding of hnRNP C to the A+U-rich sequence in vitro.
AuthorsR Nanbu, L Montero, D D'Orazio, Y Nagamine
JournalEuropean journal of biochemistry (Eur J Biochem) Vol. 247 Issue 1 Pg. 169-74 (Jul 01 1997) ISSN: 0014-2956 [Print] England
PMID9249023 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Heterogeneous-Nuclear Ribonucleoprotein Group C
  • Heterogeneous-Nuclear Ribonucleoproteins
  • RNA, Messenger
  • RNA-Binding Proteins
  • Ribonucleoproteins
  • Protein Kinase C
  • Urokinase-Type Plasminogen Activator
Topics
  • Animals
  • Breast Neoplasms (enzymology)
  • Cytoplasm (chemistry)
  • Down-Regulation
  • Female
  • Heterogeneous-Nuclear Ribonucleoprotein Group C
  • Heterogeneous-Nuclear Ribonucleoproteins
  • Humans
  • Kidney (enzymology)
  • LLC-PK1 Cells
  • Neoplasm Metastasis
  • Phosphorylation
  • Protein Kinase C (physiology)
  • RNA, Messenger (chemistry, metabolism)
  • RNA-Binding Proteins (metabolism)
  • Ribonucleoproteins (analysis, physiology)
  • Swine
  • Tumor Cells, Cultured
  • Urokinase-Type Plasminogen Activator (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: